Bringing the Patent Abuse Playbook to a New Category of Blockbuster Products A February 2024 analysis published in JAMA Network found brand name drug makers marketing a new category of weight loss drugs, glucagon-like peptide 1 (GLP-1) receptor agonists, are increasingly utilizing device patents to build patent thickets around these products to create and elongate periods of monopoly pricing power despite the drugs effectively being older diabetes medications repackaged for a different indication
Lancet 398 (10313), 18111824
BioTech USA L-Carnitina 3000 Limn Ingredientes: Agua, L-carnitina 12%, acidulante (cido ctrico), edulcorantes (sucralosa, acesulfamo-K), conservador (sorbato de potasio), aroma, colorante (amarillo ocaso FCF**)
Alternative Evidence-Based Approaches to Skin Health Evidence-based alternatives for skin brightening and health include topical treatments with proven ingredients like hydroquinone, tretinoin, vitamin C, and niacinamide
Pricing (varies by pharmacy): 10 mL vial: ~$59$65 30 mL vial: ~$99 Cost varies by manufacturer and pharmacy.[scribd] Do I Need a Prescription for Lipo C
Why Semaglutide Can Cause Nausea Semaglutide works by mimicking the hormone GLP-1 (glucagon-like peptide-1) in the body
